Elsevier is one of those publishers fighting open science. They try to claim that the government publishing government funded research in an open way will tarnish science. The argument makes no sense to me. Here is another crazy action on their part: they published a “journal” funded by Merck to promote Merck products. Merck Makes Phony Peer-Review Journal:
What’s sad is that I’m sure many a primary care physician was given literature from Merck that said, “As published in Australasian Journal of Bone and Joint Medicine, Fosamax outperforms all other medications….” Said doctor, or even the average researcher wouldn’t know that the journal is bogus. In fact, knowing that the journal is published by Elsevier gives it credibility!
As I have said the journals fighting open science should have their credibility questioned. They are putting their outdated business model above science. We should not see organizations that are focused on closing science research through deceptive publicity efforts and lobbying efforts as credible.
Related: From Ghost Writing to Ghost Management in Medical Journals – Merck Faked a Research Journal – Medical Study Integrity (or Lack Thereof) – The Future of Scholarly Publication – Fresh questions raised about prominent cardiologist’s role in “ghostwritten” 2001 meta-analysis of Vioxx trials – Science Commons: Making Scientific Research Re-useful – Publishers Continue to Fight Open Access to Science – Misleading or Deceptive Conduct – Peter Suber Response to Rep. Conyers